Protease-antiprotease imbalance driving early-onset emphysema
Alpha-1 antitrypsin quietly guards the lung against its own defenders.
AAT is a liver-made serine protease inhibitor circulating in blood.
It diffuses into lung tissue and neutralizes neutrophil elastase on contact.
One AAT molecule irreversibly traps one elastase molecule — a suicide-substrate reaction.
Elastin fibers give alveoli their stretch and recoil.
Neutrophils constantly release elastase during normal immune patrol.
Excess AAT ensures elastase is inhibited faster than it can act.
Alveolar walls stay intact across a normal lifespan.
A mutated SERPINA1 gene misfolds AAT, trapping it inside the liver.
A single amino-acid substitution (Glu342Lys) misfolds the protein.
Mutant AAT polymerizes and accumulates inside hepatocytes.
Liver accumulation can cause cirrhosis in some patients.
Lung disease results from the antiprotease shortfall reaching alveoli.
PiZZ individuals reach only 10–15% of normal serum AAT levels.
Under ~80 mg/dL, elastase inhibition capacity is overwhelmed.
Protection fails fastest in lung bases, where blood flow concentrates.
| Product | Indication | Trial Design | Key Result |
|---|---|---|---|
| PiMM (normal) | ~100–200 mg/dL | Two normal M alleles | Baseline population risk |
| PiMZ (heterozygous) | ~90 mg/dL | One M, one Z allele | Mild risk, smoking-sensitive |
| PiSZ | ~40–50 mg/dL | One S, one Z allele | Moderate deficiency |
| PiZZ (deficient) | ~10–20 mg/dL | Two Z alleles | Severe deficiency, high risk |
Without enough antiprotease, elastase digests structural lung proteins freely.
Each unopposed elastase molecule digests many elastin strands.
Damage accumulates faster than lung tissue can repair.
Cigarette smoke oxidizes a key methionine on AAT, disabling it even when present.
Smoke recruits more neutrophils and inactivates existing AAT.
PiZZ smokers develop emphysema decades earlier than nonsmokers.
Tissue damage triggers more inflammation and more neutrophils.
The protease-antiprotease imbalance widens over time.
Elastin loss collapses alveolar septa into fewer, larger airspaces.
AAT deficiency destroys the whole acinus, not just its center.
Lower lobes bear the brunt due to greater blood flow.
This lower-lobe panacinar pattern is a hallmark clue for AAT deficiency.
Destroyed elastin cannot pull airways open on exhalation.
Airways collapse early, trapping stale air.
Adjacent alveoli merge into large, thin-walled bullae.
Total gas-exchange surface area shrinks substantially.
Airflow obstruction now appears decades before typical smoker COPD.
Spirometry shows reduced FEV1/FVC well before age 45.
Symptoms often mimic asthma, delaying correct diagnosis.
AAT deficiency should be tested in COPD diagnosed before age 45.
Smokers with PiZZ lose lung function far faster than nonsmokers.
Quitting remains the single biggest modifiable factor.
Weekly IV augmentation raises serum AAT toward protective levels.
Bronchodilators and pulmonary rehab treat downstream symptoms.
First-degree relatives of PiZZ patients benefit from testing.
Early identification enables prevention before symptoms begin.